Market Wrap: Benchmark indices closed on a higher note while Nifty IT underperformed!
Market Wrap: Benchmark indices closed on a higher note while Nifty IT underperformed!

Market Wrap: Benchmark indices closed on a higher note while Nifty IT underperformed!

Sensex substantially gained by 0.26 per cent closing at 72,831.94 level, while Nifty also gained by 0.39 per cent and closed at 22,096.75 level.

Gaurav Taparia Article rating: 3.4

According to provisional data from the NSE, Foreign Institutional Investors (FIIs) sold shares worth Rs 1,826.97 crore, while Domestic Institutional Investors (DIIs) bought stocks worth Rs 3,208.87 crore on March 21.

Watch out for these penny stocks locked in the upper circuit on October 31
Watch out for these penny stocks locked in the upper circuit on October 31

Watch out for these penny stocks locked in the upper circuit on October 31

Sensex and Nifty are on a downward trajectory, with Sensex experiencing a 0.20% decline and Nifty down by 0.24%.

Vaishnavi Chauhan Article rating: 4.8

Overall market sentiment remains optimistic, with around 1919 stocks advancing compared to 1568 stocks in decline. This positive market breadth underscores a prevailing upbeat mood in the broader market.

Rs 1,622.5 crore order book: This multibagger aerospace & defense company bags massive orders worth Rs 178.54 crore; stock hits 52-week high!
Rs 1,622.5 crore order book: This multibagger aerospace & defense company bags massive orders worth Rs 178.54 crore; stock hits 52-week high!

Rs 1,622.5 crore order book: This multibagger aerospace & defense company bags massive orders worth Rs 178.54 crore; stock hits 52-week high!

Shares of the company gained more than 60 per cent in the last six months.

Praveenkumar Yadav Article rating: 4.1

Shares of the company gained more than 60 per cent in the last six months.

Upcoming collaboration: Two leading pharma company stocks to watch out for
Upcoming collaboration: Two leading pharma company stocks to watch out for

Upcoming collaboration: Two leading pharma company stocks to watch out for

US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns

Kiran Shroff Article rating: 4.5

Upcoming collaboration: Two leading pharma company stocks to watch out for                                                                                                                                                                                            US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns.

Stocks below Rs 100: Only buyers seen in these scrips on July 20
Stocks below Rs 100: Only buyers seen in these scrips on July 20

Stocks below Rs 100: Only buyers seen in these scrips on July 20

The US equity indices climbed more than 2 per cent as Netflix posted better-than-expected earnings reports and recovered losses in the number of subscribers along with cheaper ad plans in the future. 

Sayali Kotwal Article rating: 4.1

In the afternoon session on Wednesday, the headline equity indices, i.e. Sensex and Nifty 50 were trading higher as the global markets continued their gaining rally. 

Do you own this multibagger that has jumped 480 per cent in a year?
Do you own this multibagger that has jumped 480 per cent in a year?

Do you own this multibagger that has jumped 480 per cent in a year?

The shares of Indrayani Biotech soared to almost 5 per cent today after the company announced its results for the quarter and year that ended on March 31, 2022.

Sayali Kotwal Article rating: 5.0

The shares of Indrayani Biotech soared to almost 5 per cent today after the company announced its results for the quarter and year that ended on March 31, 2022.

DSIJ MINDSHARE

Mkt Commentary26-Apr, 2024

Mindshare26-Apr, 2024

Penny Stocks26-Apr, 2024

Multibaggers26-Apr, 2024

Multibaggers26-Apr, 2024

Knowledge

General26-Apr, 2024

Fundamental21-Apr, 2024

General21-Apr, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR